🏥 治験ポータル
← 治験一覧に戻る

ヘリコバクター・ピロリゲノムプロジェクト(HpGP)

基本情報

NCT ID
NCT02788214
ステータス
中止
試験のフェーズ
-
試験タイプ
観察
目標被験者数
1,000
治験依頼者名
National Cancer Institute (NCI)

概要

Helicobacter pylori is a common bacterial infection. It can lead to severe stomach problems, including stomach cancer. Researchers want to look at samples of the bacteria. These H. pylori strains will be taken from chronically infected people. They want to identify the genetic and epigenetic differences in H. pylori strains. This could help predict which people who get infected with the bacteria will get stomach cancer. This could lead to the cancer being detected earlier. It could also mean less people get stomach cancer. Objectives: To study genetic variations of H. pylori strains based on samples from chronically infected people. To identify the features of strains that might lead to severe stomach problems or stomach cancer. Eligibility: People ages 30-70 years who need an upper endoscopy or who were recently diagnosed with stomach cancer Design: Participants will be screened by the doctor who does their procedure and a study nurse. Participants who have endoscopy will have \~6 biopsies removed. These are tissue samples. They are about the size of a grain of rice. Participants will allow the study team to access reports from their stomach exam. Participants with stomach cancer will donate some of the tissue that will be removed during their clinical care. They will allow the study team to access reports of their surgery. They will also allow them to access the microscope slides of their stomach.

対象疾患

Gastric CancerNon-Atrophic GastritisIntestinal Metaplasia

実施施設 (5)

Oita University

Ōita, Japan

Kyorin University

Tokyo, Japan

HOSEI University

Tokyo, Japan

日本赤十字社愛知医療センター名古屋第二病院

Nagoya, Japan

日本医科大学千葉北総病院

Tokyo, Japan